DBD vs STE · P/E 28, rev $3.75B vs P/E 25, rev $5.46B
Diebold Nixdorf, Incorporated (DBD) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Diebold Nixdorf, Incorporated (DBD) is a software - application company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported DBD revenue for 2024-12-31 was $3.75B. Net income was -$14.5M. Revenue was up 130.3% from 2023-12-31 to 2024-12-31. DBD currently screens at market cap $2.82B and trailing P/E 28.1.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
DBD currently screens at market cap $2.82B and trailing P/E 28.1. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the DBD and STE stock pages for the full models.
Not investment advice.